Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Generex works on early diabetes test for children:

This article was originally published in Clinica

Executive Summary

Generex Biotechnology's subsidiary, Antigen Express, is developing a diagnostic kit for the early detection and screening of type 1 diabetes in young children. In a collaboration with two European diabetes centres, the company is to begin in vitro studies to identify the immune mechanisms that lead to the destruction of insulin-producing cells in the pancreas and to the onset of type 1 diabetes. The studies will focus on the role that lymphocytes play in a series of pancreatic antigens. Toronto, Canada-based Generex said that characterising these lymphocytes could lead to the development of a better screening parameter for those at risk of developing the disease, earlier diagnosis and possible intervention.






Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts